In: Accounting
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:
| 
 1  | 
 Dec. 31, 20Y3  | 
 Dec. 31, 20Y2  | 
|
| 
 2  | 
 Assets  | 
||
| 
 3  | 
 Cash  | 
 $625,650.00  | 
 $586,340.00  | 
| 
 4  | 
 Accounts receivable (net)  | 
 228,170.00  | 
 208,030.00  | 
| 
 5  | 
 Inventories  | 
 641,480.00  | 
 617,130.00  | 
| 
 6  | 
 Investments  | 
 0.00  | 
 240,290.00  | 
| 
 7  | 
 Land  | 
 328,170.00  | 
 0.00  | 
| 
 8  | 
 Equipment  | 
 706,070.00  | 
 552,300.00  | 
| 
 9  | 
 Accumulated depreciation-equipment  | 
 (165,580.00)  | 
 (147,010.00)  | 
| 
 10  | 
 Total assets  | 
 $2,363,960.00  | 
 $2,057,080.00  | 
| 
 11  | 
 Liabilities and Stockholders’ Equity  | 
||
| 
 12  | 
 Accounts payable (merchandise creditors)  | 
 $424,300.00  | 
 $404,860.00  | 
| 
 13  | 
 Accrued expenses payable (operating expenses)  | 
 41,850.00  | 
 52,880.00  | 
| 
 14  | 
 Dividends payable  | 
 23,200.00  | 
 19,880.00  | 
| 
 15  | 
 Common stock, $2 par  | 
 150,000.00  | 
 100,000.00  | 
| 
 16  | 
 Paid-in capital: Excess of issue price over par—common stock  | 
 417,500.00  | 
 280,000.00  | 
| 
 17  | 
 Retained earnings  | 
 1,307,110.00  | 
 1,199,460.00  | 
| 
 18  | 
 Total liabilities and stockholders’ equity  | 
 $2,363,960.00  | 
 $2,057,080.00  | 
The income statement for the year ended December 31, 20Y3, is as follows:
| 
 1  | 
 Sales  | 
 $5,378,129.00  | 
|
| 
 2  | 
 Cost of goods sold  | 
 3,306,510.00  | 
|
| 
 3  | 
 Gross profit  | 
 $2,071,619.00  | 
|
| 
 4  | 
 Operating expenses:  | 
||
| 
 5  | 
 Depreciation expense  | 
 $18,570.00  | 
|
| 
 6  | 
 Other operating expenses  | 
 1,755,879.00  | 
|
| 
 7  | 
 Total operating expenses  | 
 1,774,449.00  | 
|
| 
 8  | 
 Operating income  | 
 $297,170.00  | 
|
| 
 9  | 
 Other income:  | 
||
| 
 10  | 
 Gain on sale of investments  | 
 40,390.00  | 
|
| 
 11  | 
 Income before income tax  | 
 $337,560.00  | 
|
| 
 12  | 
 Income tax expense  | 
 133,650.00  | 
|
| 
 13  | 
 Net income  | 
 $203,910.00  | 
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
| a. The investments were sold for $280,680 cash. | |
| b. Equipment and land were acquired for cash. | |
| c. There were no disposals of equipment during the year. | |
| d. The common stock was issued for cash. | |
| e. There was a $96,260 debit to Retained Earnings for cash dividends declared. | 
Required
Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities.
Solution
Livers Inc
Cash Flow Statement using the direct method:
| 
 Cash Flow Statement (Direct Method of presenting cash flows from operating activities) for the year ended December 31, 20Y3j  | 
||||
| 
 Cash flow from operating activities:  | 
||||
| 
 Cash receipts from customers  | 
 $5,357,989  | 
|||
| 
 Cash paid to suppliers  | 
 ($3,311,420)  | 
|||
| 
 Cash generated from operations  | 
 $2,046,569  | 
|||
| 
 Operating expenses paid  | 
 ($1,766,909)  | 
|||
| 
 Income tax expense  | 
 ($133,650)  | 
|||
| 
 Net cash provided by operating activities  | 
 $146,010  | 
|||
| 
 Cash flow from investing activities:  | 
||||
| 
 Proceeds from sale of investment  | 
 $280,680  | 
|||
| 
 Purchase of land  | 
 ($328,170)  | 
|||
| 
 Purchase of equipment  | 
 ($153,770)  | 
|||
| 
 Net cash provided by investing activities  | 
 ($201,260)  | 
|||
| 
 Cash flow from financing activities:  | 
||||
| 
 Proceeds from issue of stock  | 
 $187,500  | 
|||
| 
 Dividends paid  | 
 ($92,940)  | 
|||
| 
 Cash flow from financing activities  | 
 $94,560  | 
|||
| 
 Net increase in cash  | 
 $39,310  | 
|||
| 
 Beginning balance of cash  | 
 $586,340  | 
|||
| 
 Ending balance of cash  | 
 $625,650  | 
|||
Workings –
Sales $5,378,129
Less: increase in accounts receivable $20,140
Cash receipts from customers $5,357,989
Cost of goods sold $3,306,510
Add: increase in inventory $24,350
Less: increase in accounts payable ($19,440)
Cash paid to suppliers $3,311,420
Operating expenses $1,755,879
Add: decrease in accrued expenses payable $11,030
Operating expenses paid $1,766,909
Cash Dividends declared $96,260
Add: beginning balance $19,880
Less: Ending balance ($23,200)
Cash dividends paid $92,940